There will be poster presentations featuring PXB-mice at EASL The International Liver Congress 2017. The Meeting will be held in Amsterdam, The Netherlands from April 19th to April 23rd.
Presentation Date：April, 20, 2017 (Thu.）
Title：Superior suppression of hepatitis B virus DNA and antigen levels in a chimeric mouse model when BB-103, a DNA-directed RNA interference agent, is coupled with standard of care drugs
Presenter：Dr. David Suhy (Benitec Biopharma)
Presentation Date：April, 21, 2017 (Fri.)
Title：No changes in the coding sequence for HBV core protein after 6 weeks of treatment of HBV infected humanized mice with NVR 3-778
Presenter：Dr. Angela Lam (Novira Therapeutics)
Presentation Date：April, 22, 2017 (Sat.)
Title：Activation of FXR by steroidal or non-steroidal agonists causes an increase in LDL-cholesterol in mice with humanized chimeric liver
Presenter：Dr. Mark Young (Intercept Pharmaceuticals, Inc.）
Our booth will be located in Exhibition Area.
Apr. 20 (Thu.) 9:30 – 16:30
Apr. 21 (Fri.) 9:30 – 16:30
Apr. 22 (Sat.) 9:30 – 16:30